Operating Lease, Right-of-Use Asset of Acumen Pharmaceuticals, Inc. from 31 Dec 2021 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Acumen Pharmaceuticals, Inc. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 31 Dec 2021 to 30 Sep 2025.
  • Acumen Pharmaceuticals, Inc. Operating Lease, Right-of-Use Asset for the quarter ending 30 Sep 2025 was $173,000, a 42% decline year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

Acumen Pharmaceuticals, Inc. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $173,000 -$123,000 -42% 30 Sep 2025 10-Q 12 Nov 2025 2025 Q3
Q2 2025 $205,000 -$120,000 -37% 30 Jun 2025 10-Q 12 Aug 2025 2025 Q2
Q1 2025 $236,000 -$117,000 -33% 31 Mar 2025 10-Q 13 May 2025 2025 Q1
Q4 2024 $266,000 -$115,000 -30% 31 Dec 2024 10-Q 12 Nov 2025 2025 Q3
Q3 2024 $296,000 +$294,000 +14700% 30 Sep 2024 10-Q 12 Nov 2024 2024 Q3
Q2 2024 $325,000 +$296,000 +1021% 30 Jun 2024 10-Q 13 Aug 2024 2024 Q2
Q1 2024 $353,000 +$286,000 +427% 31 Mar 2024 10-Q 14 May 2024 2024 Q1
Q4 2023 $381,000 +$276,000 +263% 31 Dec 2023 10-K 27 Mar 2025 2024 FY
Q3 2023 $2,000 -$131,000 -98% 30 Sep 2023 10-Q 13 Nov 2023 2023 Q3
Q2 2023 $29,000 -$138,000 -83% 30 Jun 2023 10-Q 08 Aug 2023 2023 Q2
Q1 2023 $67,000 -$134,000 -67% 31 Mar 2023 10-Q 09 May 2023 2023 Q1
Q4 2022 $105,000 +$105,000 31 Dec 2022 10-K 26 Mar 2024 2023 FY
Q3 2022 $133,000 30 Sep 2022 10-Q 14 Nov 2022 2022 Q3
Q2 2022 $167,000 30 Jun 2022 10-Q 15 Aug 2022 2022 Q2
Q1 2022 $201,000 31 Mar 2022 10-Q 16 May 2022 2022 Q1
Q4 2021 $0 31 Dec 2021 10-K 27 Mar 2023 2022 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.